On the other hand, IL-10 thwarts anti-tumoral immune responses, inhibits pro-inflammatory cytokines like TNF, and increases the level of pro-survival molecules such as ICAM-1 on the surface of CLL cells [26,27,28]. This evidence concerns the gene TNF and B-cell chronic lymphocytic leukemia.